Segment Information

6 Months Ended

Dec. 31, 2018

Note 13. Segment Information

The Company operates in one reportable segment (oncology systems group), which develops, manufactures and markets proprietary medical devices used in radiation therapy and radiosurgery for the treatment of cancer patients. The Company’s Chief Executive Officer, its Chief Operating Decision Maker, reviews financial information presented on a consolidated basis for purposes of making operating decisions and assessing financial performance. The Company does not assess the performance of its individual product lines on measures of profit or loss, or asset-based metrics.

Disaggregation of Revenues

The Company disaggregates its revenues from contracts by geographic region, as the Company believes this best depicts how the nature, amount, timing and uncertainty of revenues and cash flows are affected by economic factors. Additionally, the Company typically recognizes revenue at a point in time for product revenue and recognizes revenue over time for service revenue.

The following tables present net revenue and long-lived asset information based on geographic region. Net revenue is based on the destination of the shipments and long-lived assets are based on the physical location of the assets (in thousands):

	Three Months Ended December 31,				Six Months Ended December 31,
Net Revenue	2018		2017		2018		2017
Americas	$	28,249	$	37,754	$	60,943	$	73,777
Europe, Middle East, India and Africa		41,941		32,006		77,976		67,154
Asia Pacific		18,675		17,966		30,852		24,668
Japan		13,453		12,603		28,376		25,680
Total	$	102,318	$	100,329	$	198,147	$	191,279

	December 31,		June 30,
Property and equipment, net	2018		2018
Americas	$	17,428	$	19,698
Europe, Middle East, India and Africa		610		569
Asia Pacific		1,525		1,635
Japan		1,540		1,796
Total	$	21,103	$	23,698